News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
641,635 Results
Type
Article (53867)
Company Profile (71)
Press Release (587697)
Multimedia
Podcasts (72)
Webinars (12)
Section
Business (172499)
Career Advice (2693)
Deals (32649)
Drug Delivery (98)
Drug Development (77686)
Employer Resources (150)
FDA (15400)
Job Trends (13821)
News (305806)
Policy (29725)
Tag
Academia (2489)
Academic (2)
Accelerated approval (7)
Adcomms (21)
Allergies (91)
Alliances (42614)
ALS (96)
Alzheimer's disease (1289)
Antibody-drug conjugate (ADC) (125)
Approvals (15413)
Artificial intelligence (277)
Autoimmune disease (24)
Automation (16)
Bankruptcy (293)
Best Places to Work (10828)
BIOSECURE Act (15)
Biosimilars (109)
Biotechnology (49)
Bladder cancer (82)
Brain cancer (30)
Breast cancer (298)
Cancer (2322)
Cardiovascular disease (178)
Career advice (2280)
Career pathing (32)
CAR-T (170)
Cell therapy (465)
Cervical cancer (21)
Clinical research (63681)
Collaboration (828)
Company closure (2)
Compensation (350)
Complete response letters (22)
COVID-19 (2435)
CRISPR (49)
C-suite (273)
Cystic fibrosis (104)
Data (2351)
Decentralized trials (1)
Denatured (29)
Depression (44)
Diabetes (267)
Diagnostics (6163)
Digital health (21)
Diversity (8)
Diversity, equity & inclusion (40)
Drug discovery (118)
Drug pricing (106)
Drug shortages (24)
Duchenne muscular dystrophy (91)
Earnings (61734)
Editorial (45)
Employer branding (19)
Employer resources (131)
Events (96599)
Executive appointments (785)
FDA (16797)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (768)
Gene editing (120)
Generative AI (22)
Gene therapy (326)
GLP-1 (689)
Government (4461)
Grass and pollen (6)
Guidances (170)
Healthcare (18071)
Huntington's disease (20)
IgA nephropathy (24)
Immunology and inflammation (120)
Indications (31)
Infectious disease (2576)
Inflammatory bowel disease (139)
Inflation Reduction Act (9)
Influenza (54)
Intellectual property (99)
Interviews (525)
IPO (14958)
IRA (39)
Job creations (3386)
Job search strategy (1909)
Kidney cancer (11)
Labor market (35)
Layoffs (516)
Leadership (21)
Legal (6443)
Liver cancer (71)
Lung cancer (326)
Lymphoma (159)
Machine learning (9)
Management (51)
Manufacturing (313)
MASH (75)
Medical device (12669)
Medtech (12673)
Mergers & acquisitions (18308)
Metabolic disorders (686)
Multiple sclerosis (84)
NASH (16)
Neurodegenerative disease (93)
Neuropsychiatric disorders (28)
Neuroscience (1851)
NextGen: Class of 2025 (6233)
Non-profit (4231)
Now hiring (12)
Obesity (351)
Opinion (231)
Ovarian cancer (76)
Pain (97)
Pancreatic cancer (84)
Parkinson's disease (153)
Partnered (22)
Patents (249)
Patient recruitment (120)
Peanut (50)
People (58260)
Pharmaceutical (22)
Pharmacy benefit managers (17)
Phase I (19819)
Phase II (28029)
Phase III (20823)
Pipeline (1413)
Policy (134)
Postmarket research (2517)
Preclinical (8252)
Press Release (62)
Prostate cancer (111)
Psychedelics (27)
Radiopharmaceuticals (253)
Rare diseases (380)
Real estate (5938)
Recruiting (60)
Regulatory (20964)
Reports (36)
Research institute (2234)
Resumes & cover letters (403)
Rett syndrome (6)
RNA editing (5)
RSV (39)
Schizophrenia (70)
Series A (134)
Series B (91)
Service/supplier (9)
Sickle cell disease (57)
Special edition (12)
Spinal muscular atrophy (147)
Sponsored (27)
Startups (3241)
State (1)
Stomach cancer (9)
Supply chain (55)
Tariffs (38)
The Weekly (41)
Vaccines (670)
Venture capitalists (35)
Weight loss (217)
Women's health (34)
Worklife (19)
Date
Today (184)
Last 7 days (878)
Last 30 days (3370)
Last 365 days (30564)
2025 (11942)
2024 (32556)
2023 (36509)
2022 (46762)
2021 (51534)
2020 (50465)
2019 (44451)
2018 (33871)
2017 (30667)
2016 (29774)
2015 (35135)
2014 (28286)
2013 (24590)
2012 (25901)
2011 (26142)
2010 (24699)
Location
Africa (841)
Alabama (56)
Alaska (7)
Arizona (170)
Arkansas (13)
Asia (37594)
Australia (6640)
California (6015)
Canada (1929)
China (519)
Colorado (259)
Connecticut (276)
Delaware (153)
Europe (89631)
Florida (902)
Georgia (210)
Idaho (55)
Illinois (559)
India (25)
Indiana (292)
Iowa (10)
Japan (166)
Kansas (100)
Kentucky (24)
Louisiana (12)
Maine (61)
Maryland (864)
Massachusetts (4316)
Michigan (230)
Minnesota (373)
Mississippi (2)
Missouri (87)
Montana (29)
Nebraska (22)
Nevada (65)
New Hampshire (60)
New Jersey (1729)
New Mexico (29)
New York (1718)
North Carolina (978)
North Dakota (9)
Northern California (2636)
Ohio (203)
Oklahoma (15)
Oregon (35)
Pennsylvania (1301)
Puerto Rico (12)
Rhode Island (28)
South America (1168)
South Carolina (24)
South Dakota (1)
Southern California (2284)
Tennessee (103)
Texas (918)
United States (22613)
Utah (183)
Virginia (151)
Washington D.C. (55)
Washington State (536)
West Virginia (3)
Wisconsin (64)
641,635 Results for "european society of cardiology".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cytokinetics Announces Four Upcoming Presentations at the European Society Of Cardiology Heart Failure 2025 Congress
May 9, 2025
·
5 min read
Press Releases
Tectonic Therapeutic to Present Phase 1b Data for TX45 at European Society of Cardiology Heart Failure 2025
April 15, 2025
·
6 min read
Press Releases
Windtree Therapeutics Announces Presentation of Preclinical Data on Istaroxime and a Selective SERCA2a Activator at the European Society of Cardiology Heart Failure Conference May 17, 2025
May 12, 2025
·
6 min read
CARDIO inCode-Score (CIC-Score) Presentation at the European Society of Cardiology
GENinCode Plc gave details of a presentation by Kaiser Permanente at the European Society of Cardiology (ESC) Preventive Cardiology congress in Athens, Greece, on the ‘Joint consideration of low-density lipoprotein cholesterol (“LDL-C”) and polygenic risk for incident coronary heart disease in a multi-ethnic cohort of 48,881 individuals’ using CARDIO inCode-Score.
May 1, 2024
·
2 min read
Biotech Bay
Cytokinetics Announces Five Presentations Related to Aficamten at the European Society of Cardiology Congress 2024
Cytokinetics, Incorporated (Nasdaq: CYTK) today announced five presentations related to aficamten at the European Society of Cardiology Congress 2024, taking place in London, UK from August 30, 2024 – September 2, 2024.
May 15, 2024
·
5 min read
Drug Development
Cytokinetics Announces Primary Results From SEQUOIA-HCM Presented in Late Breaking Clinical Trial Session at the European Society of Cardiology Heart Failure 2024 Congress
Cytokinetics Announces Primary Results From SEQUOIA-HCM Presented in Late Breaking Clinical Trial Session at the European Society of Cardiology Heart Failure 2024 Congress.
May 13, 2024
·
13 min read
Biotech Bay
Cytokinetics Announces Additional Results From SEQUOIA-HCM Presented in Late Breaking Clinical Trial Session at the European Society of Cardiology Heart Failure 2024 Congress
Cytokinetics Announces Additional Results From SEQUOIA-HCM Presented in Late Breaking Clinical Trial Session at the European Society of Cardiology Heart Failure 2024 Congress.
May 13, 2024
·
15 min read
Biotech Bay
Cytokinetics to Host Investor Event and Conference Call to Discuss the Primary Results From SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congress
Cytokinetics, Incorporated announced it will host an investor event and conference call on May 13, 2024 at 4:00 PM Western European Summer Time to discuss the primary results from SEQUOIA-HCM, which are being presented in a Late Breaking Clinical Trial session at Heart Failure 2024, an International Congress of the European Society of Cardiology.
April 29, 2024
·
4 min read
Press Releases
LIB Therapeutics Announces Key Results from Presentations at 2025 European Atherosclerosis Society Meeting in Glasgow May 5-6
May 7, 2025
·
5 min read
Biotech Bay
Cytokinetics Announces Three Late Breaking Clinical Trial Presentations Relating to SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congress
Cytokinetics, Incorporated today announced three Late Breaking Clinical Trial presentations relating to SEQUOIA-HCM, the pivotal Phase 3 clinical trial of aficamten in patients with symptomatic obstructive hypertrophic cardiomyopathy (HCM), at Heart Failure 2024, an International Congress of the European Society of Cardiology, taking place in Lisbon, Portugal from May 11, 2024 – May 14, 2024.
April 10, 2024
·
5 min read
1 of 64,164
Next
